Goldman Sachs is catching fresh heat over massive bonuses it has pledged to CEO David Solomon and his No. 2 executive John Waldron — with powerful shareholder voting advisors slamming the payout ...

Ahead of the Trump administration’s so-called “liberation day” on April 2, which will clarify the extent of U.S. tariff actions and spur likely reprisals from other countries, Goldman Sachs ...

The US economy faces a growing risk of a recession as surging tariffs threaten to stunt growth, reignite inflation and lift unemployment, according to Goldman Sachs. The Wall Street bank warned ...

April 4 (Reuters) - Goldman Sachs lowered its forecast for Brent crude's average price this year by 5.5% to $69 a barrel and for WTI prices by 4.3% to $66, citing the risks of higher OPEC+ supply ...

The outlook for the stock market is becoming increasingly uncertain, thanks largely to the potential impact of an escalating global trade war. Strategists at Goldman Sachs on Sunday night slashed ...

April 2 (Reuters) - Russian President Vladimir Putin has authorised Armenian investment fund Balchug Capital to buy shares in nine major companies owned by Goldman Sachs' Russian subsidiary ...

Try it free for 7 days On Thursday, Goldman Sachs analyst Brooke Roach discussed the impact of the U.S. reciprocal tariffs on retail companies. On April 2, President Trump announced reciprocal ...

The bank lowered its 2025 GDP growth forecast to 1%. Goldman Sachs raised its year-end unemployment-rate forecast to 4.5%. It expects consecutive rate cuts by the Federal Reserve in July ...

Goldman Sachs Group Inc. is expanding its private equity offering to wealthy individuals across Wall Street and beyond, in the latest sign of investment firms gradually broadening access to the ...

Goldman Sachs Group Inc. economists now forecast both the Federal Reserve and European Central Bank will cut interest rates three times this year as President Donald Trump’s tariffs weigh on ...

Eyewatering $80 million bonuses offered to two top brass at i nvestment bank Goldman Sachs are 'excessive', shareholders' advisers have warned. Investors are being urged reject the proposed ...

Vaxcyte stock opened at $32.23 on Tuesday. The stock has a market capitalization of $4.15 billion, a price-to-earnings ratio of -7.01 and a beta of 1.02. Vaxcyte has a 52-week low of $30.12 and a ...